Sanat Chattopadhyay
Independent DirectorMr. Sanat Chattopadhyay is Independent Director of Ashland Inc. since November 13, 2023. Mr. Chattopadhyay was Executive Vice President and President of Merck Manufacturing Division at Merck & Co., Inc. since March 2016 until 2026and served as its Senior Vice President of Operations at Merck Manufacturing Division from November 2009 to March 2016. He is an Executive Vice President and President of MSD Manufacturing Division at Merck Sharp & Dohme LLC. Mr. Chattopadhyay was instrumental in transforming Merck Vaccines’ manufacturing and supply to grow and globalize its vaccines business. He also played a key part in leading the company’s launch of KEYTRUDA (pembrolizumab) in record time by mobilizing a cross-divisional effort to overcome commercialization and supply constraints. Prior to Merck, Mr. Chattopadhyay held leadership positions at Wyeth Pharmaceuticals, Aventis, Hoechst Marion Roussel and Hoechst India. Mr. Chattopadhyay is a broadly experienced global executive who brings strong industry leadership in manufacturing, distribution, supply chain and more. He has led complex operations that span 22 countries including cutting-edge manufacturing technology while successfully navigating the ever-changing, globally complex and heavily regulated industry of biopharmaceuticals. Mr. Chattopadhyay holds a postgraduate degree in Industrial Engineering from the National Institute of Industrial Engineering and a Bachelor of Science in Chemical Engineering from Jadavpur University, Kolkata, India.
Positions
- Company NameAshland Inc.Stock CodeASHPositionIndependent DirectorColleagues
- GNGuillermo NovoChairman & CEO
- WCWilliam C. WhitakerSenior VP, CFO & Director of Investor Relations
- OMOsama M. MusaSenior VP & CTO
- JPJames P. MinicucciSenior VP & GM of Personal Care
- AFAlessandra Faccin AssisSenior VP and GM of Life Sciences & Intermediates
- JAJerome A. PeribereIndependent Director
- SFSuzan F. HarrisonIndependent Director
- SAScott A. TozierIndependent Director
